Retrospective study comparing anti‐EGFR monoclonal antibody plus cisplatin‐based chemoradiotherapy versus chemoradiotherapy alone for stage II‐IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression-Reference-Cited by-同舟云学术

Retrospective study comparing anti‐EGFR monoclonal antibody plus cisplatin‐based chemoradiotherapy versus chemoradiotherapy alone for stage II‐IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression

Published:2019-04-29 Issue:4 Volume:44 Page:572-580
ISSN:1749-4478
Container-title:Clinical Otolaryngology
language:en
Short-container-title:Clin Otolaryngol

Author:

Mao Linwei¹²^ORCID,Tan Jiajie¹,Wang Fan¹,Luo Yunfan¹,Liu Wei¹,Zeng Fangfang¹,Yu Bolong¹,Huang Haoran¹,Lu Juan¹,Peng Xiaohong¹,Liu Xiong¹

Affiliation:

1. Department of Otolaryngology, Head and Neck Surgery, Nanfang Hospital Southern Medical University Guangzhou China

2. Department of Otolaryngology, Affiliated Putian Hospital Southern Medical University (Affiliated Hospital of Putian College) Putian China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/coa.13340

Reference33 articles.

1. The prevalence and prevention of nasopharyngeal carcinoma in China

2. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

3. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

4. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Treatment outcomes of a prospective, multicentric clinical study

5. EGFR Antagonists in Cancer Treatment

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis;Current Cancer Drug Targets;2024-09

2. Advances of radiotherapy combined with targeted therapy for nasopharyngeal carcinoma;Radiation Medicine and Protection;2023-12

3. Prognostic value of circulating Epstein-Barr virus DNA level post-induction chemotherapy for patients with nasopharyngeal carcinoma: A recursive partitioning risk stratification analysis;Radiotherapy and Oncology;2023-08

4. EGFR, VEGF, and angiogenesis promote the development of lipoma in the oral cavity;Brazilian Dental Journal;2023-03

5. Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis;BioMed Research International;2023-02-06